Develops adeno-associated virus gene therapies for rare and chronic diseases.
| Title |
|---|
| Senior Medical Science Liaison - DMD/Neuromuscular (South) Full Time · $170K-$230K · 3+ YOE United States · Remote |
| (Sr.) Director, GCP & GLP QA Full Time · $190K-$330K · 10+ YOE Rockville, Maryland, United States · Hybrid |
| Senior Medical Science Liaison - Retina Full Time · $170K-$230K · 3+ YOE United States · Remote |
| Senior Director, Global Program Development Lead - DMD/Neuromuscular Full Time · $235K-$335K · 8+ YOE Rockville, Maryland, United States · Onsite |
| Senior Medical Science Liaison - DMD/Neuromuscular (Northeast) Full Time · $170K-$230K · 3+ YOE United States · Remote |
| Senior Director/Director, Medical Science Liaisons (Neuromuscular/DMD) Full Time · 5+ YOE United States · Remote |
| Activities | Gene therapy developmentAdeno-associated virus engineeringBiopharmaceutical manufacturingClinical research operationsTherapeutic drug discovery |
| Headquarters | US |
| Industries | BiotechnologyPharmaceuticals |
| Name | REGENXBIO |
| Employees | 394 |
| Type | Public |
| Tagline | Develops adeno-associated virus gene therapies for rare and chronic diseases. |
| Founded | 2,008 |
| Website | regenxbio.com |
| Stock Exchange | NASDAQ |
| Stock Symbol | RGNX |